In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

News

Percepta Nucleic Acid Purification (China) Dashboard Featured in GEN

percepta

17th Jul, 2013

News

0

Carlsbad, Calif. – Just a fraction of the many insights uncovered in Percepta’s 2013 Series One Nucleic Acid Purification (China) Life Science Dashboard™ was featured in the latest issue of Genetic Engineering and Biotechnology News. You can see the article here: GEN (Jul 1, 2013 (Vol. 33, No. 13)) .  To learn more about obtaining a complete version of…

read more >

Percepta Survey Finds Personnel, Reagent and Instrument Spending in Academic Research Labs Negatively Affected Both Prior to and Post Budget Sequester

percepta

15th Apr, 2013

News

0

CARLSBAD, CALIFORNIA – Though the U.S. Federal government implemented budget sequestration on March 1st, canceling $85 billion in budgetary resources across the Federal government for the remainder of the 2013 fiscal year, U.S. academic researchers spend on life science reagents and instruments decreased as early as October, 2012, according to Percepta’s recent benchmarking study.

The study objectives were to understand…

read more >

Growing at an Attractive Rate, the Fluorescent Imaging Research Market Presents Promising Opportunities for New Product Development

percepta

11th Mar, 2013

News

4

Life Technologies Dominates the Market, while Abcam and BD Biosciences Maintain a Strong Presence.
Carlsbad, Calif. – March 11, 2013: Percepta Associates announces the launch of its Fluorescent Imaging Life Science Dashboard™ market research report revealing Life Technologies (including Molecular Probes and Invitrogen brands), Abcam and BD Biosciences as leading suppliers across various segments.  Market segments analyzed in this report…

read more >

BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems Emerge as Market Leaders in Relatively Stable, Immunoassay Research Market – Revealed in New Life Science Dashboard™ from Percepta Associates

percepta

23rd Feb, 2013

News

0

However, GE/Amersham and Thermo Fisher Scientific Prevail for Certain Chemiluminescent ELISA Segments.

CARLSBAD, Calif.–(BUSINESS WIRE)–Today Percepta Associates launched its Quantitative Immunoassay Life Science Dashboard™ market research report revealing BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems as leading suppliers in the immunoassay market which includes: colorimetric, chemiluminescent and fluorescent ELISAs, as well as electrochemiluminescence and bead-based…

read more >

Growth of Chinese Cell Culture Market Driven Largely by Fetal Bovine Serum Reported in 2012 Chinese Cell Culture Life Science Dashboard™

percepta

25th Sep, 2012

News

0

Market Report from Percepta Associates Chinese Researchers more willing to switch between cell culture suppliers for improved service and support

Carlsbad, Calif. – September 25, 2012 – Today, Percepta Associates announced the launch of its Series One 2012 Chinese Cell Culture Life Science Dashboard™ market research report, providing rapid access to actionable key market indicators for the Chinese cell culture…

read more >

Life Technologies Solidifies Leadership Position in Mammalian Cell Culture Market Reported in 2012 Cell Culture Life Science Dashboard™ Market Report from Percepta Associates

percepta

5th Sep, 2012

News

0

Sigma, Thermo Fisher, MediaTech and Lonza Jostle for Second Position Revealing a Changing Competitive Landscape Compared to 2010 Cell Culture Life Science DashboardTM Findings

Carlsbad, Calif. – September 5, 2012 – Today, Percepta Associates announces the launch of its Series Four 2012 Cell Culture Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the…

read more >

Opportunities for Workflow Improvements at Every Stage of Protein Electrophoresis & Western Analysis

percepta

1st Feb, 2012

News

0

Revealed in New Protein Electrophoresis & Western Analysis Life Science DashboardTM from Percepta Associates

Carlsbad, Calif. – February 1, 2012 – Today, Percepta Associates announces the launch of the 2012 Protein Electrophoresis & Western Analysis, Series 1 Life Science DashboardTM market research report. This Dashboard reveals key market indicators, such as market size, market shares, growth rates, customer satisfaction/ propensity…

read more >

Qiagen Sweeps all 13 Market Segments in New Percepta Nucleic Acid Isolation Report

percepta

17th Oct, 2011

News

0

Nucleic Acid Purification Series 3 Life Science DashboardTM from Percepta Associates shows Qiagen market share declines in small scale plasmid isolation offset by gains in total RNA purification segments

Carlsbad, Calif. – October 17, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Purification Series 3 Life Science DashboardTM market research report, providing rapid access to…

read more >

Life Technologies Maintains Leadership in Research Market for Amplification Reagents and Instruments

percepta

10th Oct, 2011

News

0

Researchers are looking to lower priced reagent options as budget purse strings tighten

Carlsbad, Calif. – October 10, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Amplification Series 3 Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the nucleic acid amplification market. The 2011 Dashboard draws comparisons to…

read more >

Flow Cytometry Market Leaders Must Look to Reagent Segment for Growth in 2011

percepta

9th Aug, 2011

News

0

Researchers demand wider array of antibody product offerings from preferred suppliers for proteins of interest

Carlsbad, Calif. – August 9, 2011 – Today, Percepta Associates announced the launch of the 2011 Flow Cytometry Series 1 Life Science DashboardTM market research report. This report provides rapid access to actionable key market indicators for both reagents and instruments in the flow cytometry…

read more >

Copyright © 2024 Percepta Associates Inc. All rights reserved. Terms & Conditions.